Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type (2014-2025) 1.4.2 Cystoscopy 1.4.3 Biopsy 1.4.4 Intravenous Pyelogram 1.4.5 CT Scan 1.4.6 Kidney Ultrasound 1.4.7 Others 1.5 Market by Application 1.5.1 Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2019-2025) 1.5.2 Hospitals 1.5.3 Pharmaceutical Labs 1.5.4 Genomics Laboratories 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Kidney Cancer Therapeutics and Diagnostics Market Size 2.2 Kidney Cancer Therapeutics and Diagnostics Growth Trends by Regions 2.2.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Regions (2019-2025) 2.2.2 Kidney Cancer Therapeutics and Diagnostics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Kidney Cancer Therapeutics and Diagnostics Market Size by by Players 3.1.1 Global Kidney Cancer Therapeutics and Diagnostics Revenue by by Players (2014-2019) 3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by by Players (2014-2019) 3.1.3 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI) 3.2 Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Area Served 3.3 Key Players Kidney Cancer Therapeutics and Diagnostics Product/Solution/Service 3.4 Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2014-2019) 4.2 Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2014-2019) 5 North America 5.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size (2014-2019) 5.2 Kidney Cancer Therapeutics and Diagnostics Key Players in North America 5.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type 5.4 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application 6 Europe 6.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size (2014-2019) 6.2 Kidney Cancer Therapeutics and Diagnostics Key Players in Europe 6.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type 6.4 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application 7 China 7.1 China Kidney Cancer Therapeutics and Diagnostics Market Size (2014-2019) 7.2 Kidney Cancer Therapeutics and Diagnostics Key Players in China 7.3 China Kidney Cancer Therapeutics and Diagnostics Market Size by Type 7.4 China Kidney Cancer Therapeutics and Diagnostics Market Size by Application 8 International Players Profiles 8.1 Bayer 8.1.1 Bayer Company Details 8.1.2 Company Description and Business Overview 8.1.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.1.4 Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019)) 8.1.5 Bayer Recent Development 8.2 Hoffmann La Roche 8.2.1 Hoffmann La Roche Company Details 8.2.2 Company Description and Business Overview 8.2.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.2.4 Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.2.5 Hoffmann La Roche Recent Development 8.3 GlaxoSmithKline 8.3.1 GlaxoSmithKline Company Details 8.3.2 Company Description and Business Overview 8.3.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.3.4 GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.3.5 GlaxoSmithKline Recent Development 8.4 Novartis 8.4.1 Novartis Company Details 8.4.2 Company Description and Business Overview 8.4.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.4.4 Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.4.5 Novartis Recent Development 8.5 Pfizer 8.5.1 Pfizer Company Details 8.5.2 Company Description and Business Overview 8.5.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.5.4 Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.5.5 Pfizer Recent Development 8.6 Abbott Laboratories 8.6.1 Abbott Laboratories Company Details 8.6.2 Company Description and Business Overview 8.6.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.6.4 Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.6.5 Abbott Laboratories Recent Development 8.7 Amgen 8.7.1 Amgen Company Details 8.7.2 Company Description and Business Overview 8.7.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.7.4 Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.7.5 Amgen Recent Development 8.8 Genentech 8.8.1 Genentech Company Details 8.8.2 Company Description and Business Overview 8.8.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.8.4 Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.8.5 Genentech Recent Development 8.9 Cerulean Pharma 8.9.1 Cerulean Pharma Company Details 8.9.2 Company Description and Business Overview 8.9.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.9.4 Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.9.5 Cerulean Pharma Recent Development 8.10 Seattle Genetics 8.10.1 Seattle Genetics Company Details 8.10.2 Company Description and Business Overview 8.10.3 Kidney Cancer Therapeutics and Diagnostics Introduction 8.10.4 Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) 8.10.5 Seattle Genetics Recent Development 9 Market Forecast 2019-2025 9.1 Market Size Forecast by Product (2019-2025) 9.2 Market Size Forecast by Application (2019-2025) 9.3 Market Size Forecast by Regions 9.4 North America 9.5 Europe 9.6 China 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.1.1 Research Programs/Design 11.1.1.2 Market Size Estimation 11.1.1.3 Market Breakdown and Data Triangulation 11.1.2 Data Source 11.1.2.1 Secondary Sources 11.1.2.2 Primary Sources 11.2 Disclaimer 11.3 Author Details

List of Tables and Figures Table Kidney Cancer Therapeutics and Diagnostics Key Market Segments Table Key Players Kidney Cancer Therapeutics and Diagnostics Covered Table Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Cystoscopy Figures Table Key Players of Cystoscopy Figuer Biopsy Figures Table Key Players of Biopsy Figuer Intravenous Pyelogram Figures Table Key Players of Intravenous Pyelogram Figuer CT Scan Figures Table Key Players of CT Scan Figuer Kidney Ultrasound Figures Table Key Players of Kidney Ultrasound Figuer Others Figures Table Key Players of Others Table Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth by Application 2019-2025 (Million US$) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application in 2018 & 2025 Figure Hospitals Case Studies Figure Pharmaceutical Labs Case Studies Figure Genomics Laboratories Case Studies Figure Others Case Studies Figure Kidney Cancer Therapeutics and Diagnostics Report Years Considered Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Regions 2019-2025 (Million US$) Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Regions 2019-2025 (Million US$) Table Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions 2014-2019 Figure Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions 2014-2019 Figure Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Kidney Cancer Therapeutics and Diagnostics Revenue by by Players (2014-2019) (Million US$) Table Global Kidney Cancer Therapeutics and Diagnostics Market Share by by Players (2014-2019) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Share by by Players in 2018 Table Global Kidney Cancer Therapeutics and Diagnostics by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Kidney Cancer Therapeutics and Diagnostics Product/Solution/Service Table Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market Table Mergers & Acquisitions, Expansion Plans Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2014-2019) (Million US$) Table Global Kidney Cancer Therapeutics and Diagnostics Market Size Share by Type (2014-2019) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2014-2019) Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2014-2019) (Million US$) Table Global Kidney Cancer Therapeutics and Diagnostics Market Size Share by Application (2014-2019) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2014-2019) Figure Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Application in 2018 Figure North America Kidney Cancer Therapeutics and Diagnostics Market Size 2014-2019 (Million US$) Table North America Key Players Kidney Cancer Therapeutics and Diagnostics Revenue (2018-2019) (Million US$) Table North America Key Players Kidney Cancer Therapeutics and Diagnostics Market Share (2018-2019) Table North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type 2014-2019 (Million US$) Table North America Kidney Cancer Therapeutics and Diagnostics Market Share by Type 2014-2019 Table North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application 2014-2019 (Million US$) Table North America Kidney Cancer Therapeutics and Diagnostics Market Share by Application 2014-2019 Figure Europe Kidney Cancer Therapeutics and Diagnostics Market Size 2014-2019 (Million US$) Table Europe Key Players Kidney Cancer Therapeutics and Diagnostics Revenue (2018-2019) (Million US$) Table Europe Key Players Kidney Cancer Therapeutics and Diagnostics Market Share (2018-2019) Table Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type 2014-2019 (Million US$) Table Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Type 2014-2019 Table Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application 2014-2019 (Million US$) Table Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Application 2014-2019 Figure China Kidney Cancer Therapeutics and Diagnostics Market Size 2014-2019 (Million US$) Table China Key Players Kidney Cancer Therapeutics and Diagnostics Revenue (2018-2019) (Million US$) Table China Key Players Kidney Cancer Therapeutics and Diagnostics Market Share (2018-2019) Table China Kidney Cancer Therapeutics and Diagnostics Market Size by Type 2014-2019 (Million US$) Table China Kidney Cancer Therapeutics and Diagnostics Market Share by Type 2014-2019 Table China Kidney Cancer Therapeutics and Diagnostics Market Size by Application 2014-2019 (Million US$) Table China Kidney Cancer Therapeutics and Diagnostics Market Share by Application 2014-2019 Table Bayer Company Details Table Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Bayer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Bayer Recent Development Table Hoffmann La Roche Company Details Table Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Hoffmann La Roche Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Hoffmann La Roche Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table GlaxoSmithKline Recent Development Table Novartis Company Details Table Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Novartis Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Pfizer Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Abbott Laboratories Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Abbott Laboratories Recent Development Table Amgen Company Details Table Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Amgen Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Amgen Recent Development Table Genentech Company Details Table Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Genentech Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Genentech Recent Development Table Cerulean Pharma Company Details Table Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Cerulean Pharma Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Cerulean Pharma Recent Development Table Seattle Genetics Company Details Table Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business 2014-2019 (Million US$) Figure Seattle Genetics Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2014-2019) Table Seattle Genetics Recent Development Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Regions (Million US$) 2019-2025 Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size Share by Regions (2019-2025) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size Share by Regions in 2025 Figure North America Kidney Cancer Therapeutics and Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure Europe Kidney Cancer Therapeutics and Diagnostics Market Size Forecast (2019-2025)(Million USD) Figure China Kidney Cancer Therapeutics and Diagnostics Market Size Forecast (2019-2025)(Million USD) Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Product (2019-2025) (Million US$) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size by Product (2019-2025) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size by Product in 2025 Table Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2025) (Million US$) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2019-2025) Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bayer Hoffmann La Roche GlaxoSmithKline Novartis Pfizer Abbott Laboratories Amgen Genentech Cerulean Pharma Seattle Genetics